IP Library Granted Patent US 7,988,645
Granted Patent B2
US 7,988,645 · App. 11/744,063 · Granted Aug 2, 2011

Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,988,645
App. No.
11/744,063
Granted
Aug 2, 2011
Kind
B2
Abstract

A lancing device, an embodiment of which controls the advancement and retraction of a lancet by monitoring the position of the lancet in conjunction with a lancet controller which incorporates a feedback loop for modulating the lancet driver to follow a predetermined tissue lancing profile.

Claims (21)

1. A method for lancing tissue comprising the steps of:

selecting a desired profile from a set of alternative profiles having characteristic phases for lancet advancement and retraction;

lancing a user according to said profile using an electronic drive force generator;

determining a lancing profile trait during each of said characteristic phases;

optimizing said profile for subsequent lancing based upon said profile trait as a function of the characteristic phases for lancet advancement and retraction; and

subsequently lancing the user according to the optimized profile.

2. A method for lancing tissue according to claim 1 wherein: said profile trait comprises success of obtaining a blood sample from said user.

3. A method for lancing tissue according to claim 1 wherein: said profile trait comprises blood volume obtained from said user.

4. A method for lancing tissue according to claim 1 wherein: said profile trait comprises pain perceived by said user.

5. A method for lancing tissue according to claim 1 wherein: said profile trait comprises a relative time associated with skin deformation.

6. A method for lancing tissue according to claim 1 wherein: said profile trait comprises dwell time in said tissue of said user.

7. A method for lancing tissue according to claim 1 , wherein: said characteristic phases comprise a completed cycle of advancing and retracting said lancet into and out of a tissue to obtain a blood sample.

8. A method for lancing tissue according to claim 1 , wherein: said characteristic phases further comprising: a lancet introduction phase comprising a longitudinal advancement of the lancet in a first direction into said tissue; a lancet rest phase comprising a termination of said longitudinal advancement of said lancet wherein said lancet reaches a maximum depth of tissue penetration and becomes relatively stationary; and a lancet retraction phase comprising a longitudinal retraction of said lancet in a second direction opposite said first direction out of said tissue.

9. A method for lancing tissue according to claim 8 , wherein: said lancet introduction phase comprises a first time duration; and said lancet retraction phase comprises a second time duration which is relatively longer than said first time duration.

10. A method for lancing tissue according to claim 8 , wherein: said lancet introduction phase further comprises: a lancet launch phase comprising a longitudinal advancement of the lancet in said first direction from a stationary loaded lancing position toward the tissue; a tissue contact phase including a point of initial contact between said distal end of said lancet and the tissue; a tissue deformation phase comprising deforming said tissue while longitudinally advancing said lancet in said first direction; a tissue lancing phase comprising penetrating said tissue while longitudinally advancing said lancet in said first direction.

11. A method for lancing tissue according to claim 10 , wherein: said introduction phase varies according to said tissue deformation phase, such that said lancing follows said profile.

12. A method for lancing tissue according to claim 10 , wherein: said introduction phase varies according to said tissue contact phase, such that said lancing follows said profile.

13. A method for lancing tissue according to claim 8 , wherein: said lancet retraction phase further comprises:

a primary lancet retraction phase comprising a longitudinal retraction of the lancet in said second direction from a relatively stationary position during said rest phase where said skin pushes said lancet in said second direction ; a secondary lancet retraction phase comprising a longitudinal retraction of the lancet in said second direction from said position where said skin stops pushing said lancet in said second direction to a position and said lancet is pulled out of said skin in said second direction; and a lancet exit phase comprising a exit of the lancet from the skin.

14. A method for lancing tissue according to claim 13 , wherein: said retraction phase varies according to said primary retraction phase, such that said lancing follows said profile.

15. A method for lancing tissue according to claim 13 , wherein : said retraction phase varies according to said secondary retraction phase, such that said lancing follows said profile.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2012
From: PELIKAN TECHNOLOGIES, INC.
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 028229/0524 →
RELEASE OF SECURITY INTEREST Recorded Mar 2, 2010
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 024016/0492 →
SECURITY AGREEMENT Recorded Dec 18, 2008
From: PELIKAN TECHNOLOGIES, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021998/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2007
From: FREEMAN, DOMINIQUE M; ALDEN, DON
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 019486/0641 →